All Type of News
Korea’s trade deal with EU affects local health and medical industry
Trade Minister Kim Jong-hoon and his European Union (EU) ounterpart Catherine Ashton initialed the bilateral free trade pact (FTA) in Belgium on October 15.
They plan to officially sign the trade pact within the f...
ZPK urged to create more fair competition
Zuellig Pharma Korea (ZPK) should not interfere with its domestic wholesalers’ efforts to make direct dealing with multinational companies, the Korean Pharmaceutical Association (KPA) in October 25 statement.
The s...
KPMA suggests hike in health insurance premiums
The Korea Pharmaceutical Manufactures Association (KPMA) recommended an increase in the contribution rate in Korea's national health insurance plan in a press interview on October 15.
Uh Joon-sun, chairman of KPMA...
Dong-A expands in painkiller market
Boosted by robust sales of a new isopropylantipyrine (IPA)-free painkiller “Amcilon Q”, Dong-A Pharm is attempting to become a leading player in the domestic analgesic market, which has been dominated by Samjin’ Gewor...
Government mulls switching OTC plan over 2,000 prescription drugs
The government is considering switching 1,700 insurance covered drugs into over-the-counter (OTC) products in the latter half of next year, the Ministry of Health, Welfare and Family Affairs said on October 14.
In ...
Wholesalers give some multinationals ultimatum
Some multinational firms, who promised to expand direct transaction with domestic wholesalers, have met a major hurdle with the Korea Association of Pharmaceutical Wholesaler issuing “expansion of direct transaction w...
Drug price cut corners local drug makers
The Korean government’s strong will to reduce snowballing medication costs has baffled domestic pharmaceutical firms as they have been largely dependent on producing and marketing generic drugs instead of inventing ne...
Chong Kun Dang shows continuous sales growth for 6 consecutive months
Chong Kun Dang Pharmaceutical has witnessed ceaseless sales growth rates for six consecutive months due to robust sales of its Cozaar generic, according to data released by market analysts.
The domestic ethical ma...
Local biopharmaceutical firm to conduct phase 3 trial for Enbrel
Biotrion Co., an affiliated biopharmaceutical company of Futureinfonet in Korea, says it has received approval from the Korea Food and Drug Administration to conduct phase 3 clinical trial covering its biosimilar drug...
Debate flares up over domestic generic drug price
The Korean Research based Pharmaceutical Industry Association (KRPIA) and the Korea Pharmaceutical Manufacturers Association (KPMA) have conflicting views on the prices of local generic drugs.
The KRPIA said in its...
